Evidence map›Paper›PMID 37251897›Full record

ArticleHeliyon2023

Sensitivity and specificity of

Francesca Soggiu, Jacopo Sabbatinelli, Angelica Giuliani, Riccardo Benedetti, Andrea Marchegiani, Francesco Sgarangella, Alberto Tibaldi, Daniela Corsi, Antonio Domenico Procopio, Sara Calgaro and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Francesca SoggiuDipartimento di Prevenzione, ATS Sardegna, Italy.
Jacopo SabbatinelliDepartment of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
Angelica GiulianiDepartment of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
Riccardo BenedettiAST, Macerata, Italy.
Andrea MarchegianiSchool of Biosciences and Veterinary Medicine, University of Camerino, Matelica, Italy.
Francesco SgarangellaDipartimento di Prevenzione, ATS Sardegna, Italy.
Alberto TibaldiAST, Macerata, Italy.
Daniela CorsiAST, Macerata, Italy.
Antonio Domenico ProcopioDepartment of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
Sara CalgaroProgetto Serena APS, Cinto Caomaggiore, Italy.
Fabiola OlivieriDepartment of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
Andrea SpaternaSchool of Biosciences and Veterinary Medicine, University of Camerino, Matelica, Italy.
Roberto ZampieriProgetto Serena APS, Cinto Caomaggiore, Italy.
Maria Rita RippoDepartment of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
C19-Screendog study group
Marche Polytechnic University · ITUniversity of Macerata · ITArca Progetti (Italy) · ITATS Sardegna (Italy) · ITUniversità di Camerino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trained dogs can recognize the volatile organic compounds contained in biological samples of patients with COVID-19 infection. We assessed the sensitivity and specificity of

Identifiers

PMID37251897
PMCPMC10209336
OpenAlexW4366978144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.